Skip to main content

Metamizol

Metamizole

Der Schmerz volume 29, pages 227–228 (2015)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Literatur

  1. Lampl C, Likar R (2014) Metamizol: Wirkmechanismen, Interaktionen und Agranulozytoserisiko. Schmerz 28:584–590

    Article  CAS  PubMed  Google Scholar 

  2. Pierre SC, Schmidt R, Brenneis C et al (2007) Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol 151:494–503

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Rogosch T, Sinning C, Podlewski A et al (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem 20(1):101–107

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Siebel JS, Beirith A, Calixto JB (2004) Evidence for the involvement of metabotropic glutamatergic, neurokinin 1 receptor pathways and protein kinase C in the antinociceptive effect of dipyrone in mice. Brain Res 1003:61–67

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

K. Güttler gibt an, dass kein Interessenkonflikt besteht.

Author information

Affiliations

  1. Institut für Pharmakologie, Universität Köln, Gleueler Str. 24, 50931, Köln, Deutschland

    K. Güttler

Authors
  1. K. Güttler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Güttler.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Güttler, K. Metamizol. Schmerz 29, 227–228 (2015). https://doi.org/10.1007/s00482-015-1520-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-015-1520-0